Summary
The article teases an underappreciated U.S. public company with direct humanoid exposure, arguing that the market's excitement over the CCXI/Agility SPAC is premature given unknown financials, and that a better pure-play exists. The author plans to reveal this company and explain why it could re-rate, suggesting a potential hidden opportunity for humanoid investors.
-
•The market is bidding up CCXI (Agility Robotics SPAC) without understanding its financial condition.
-
•Tesla (TSLA) is considered too diluted to serve as a direct humanoid investment.
-
•An unnamed U.S. public company has placed a large bet on humanoids, likely unknown to most investors.
-
•The author believes this company could re-rate and plans to detail its thesis in a follow-up deep dive.